Opioids
by Madeleine Deye | Jan 21, 2022 | Commentary, Perspectives
It should not be more difficult for health care providers to prescribe life-saving medications that treat opioid use disorder than to prescribe addictive opioid pills themselves. Yet, that is the reality clinicians face today. Fortunately, there is an opportunity to...
by Madeleine Deye | Oct 4, 2021 | Commentary, Perspectives
Introduction As the United States continues grappling with the COVID-19 pandemic, a long-standing and worsening public health crisis escalates. In 2020, more than 93,000 people in the U.S. died of drug-related overdoses largely due to the synthetic opioid...
by Jenna Ogilvie | Apr 5, 2021 | Discussion Paper, Perspectives
Introduction The United States is in the midst of a multifactorial drug overdose and death epidemic. In 2020, over 80,000 deaths [15] in the U.S. were attributed to drug overdose, more than 50,000 of which were opioid-related. This is an increase of...
by Jenna Ogilvie | Mar 29, 2021 | Commentary, Perspectives
The week of February 14, 2021, will be forever ingrained in the memories of Central Texas residents. Winter Storm Uri blanketed the region in ice and snow, leading to devastating and unprecedented circumstances. Most residents lost electricity, and the water...
by Jenna Ogilvie | Nov 9, 2020 | Commentary, Perspectives
The opioid epidemic is raging within the COVID-19 pandemic, with more than 40 states reporting increases in opioid-related overdoses and deaths. COVID-19 has disrupted health care services, disproportionately affecting already marginalized populations. Prior to...
by Jenna Ogilvie | Oct 26, 2020 | Discussion Paper, Perspectives
The United States is in the midst of an unprecedented crisis of prescription and illicit opioid misuse, use disorder, and overdose. In 2018, nearly 47,000 Americans died from an overdose involving opioids [174]. In 2018, 10.3 million people aged 12 years...
by Jenna Ogilvie | Aug 10, 2020 | Discussion Paper, Perspectives
Introduction Ensuring high-quality, respectful, and appropriate management of chronic non-cancer pain (CNCP) in the context of the US opioid crisis is a critical and complex endeavor. At the end of the twentieth century, opioids became the standard...
by Jenna Ogilvie | Apr 27, 2020 | Discussion Paper, Perspectives
ABSTRACT | Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost four in five Americans with OUD do not receive any form of treatment. The gap in access to evidence-based care, including treatment with...
by Jenna Ogilvie | Sep 9, 2019 | Commentary, Perspectives
Those working on changing the course of the opioid crisis cannot afford to overlook simple solutions that could bring timely, positive results. Changing the policies that impact buprenorphine prescribing could have immediate impacts on access to...
by Jenna Ogilvie | Sep 19, 2016 | Discussion Paper, Perspectives
About the Vital Directions for Health and Health Care Series This publication is part of the National Academy of Medicine’s Vital Directions for Health and Health Care Initiative, which commissioned expert papers on 19 priority focus areas for U.S. health policy by...
